Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
September 14 2016 - 12:50PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported):
September
14, 2016
______________
QUINTILES TRANSNATIONAL HOLDINGS INC.
(Exact
name of registrant as specified in its charter)
______________
North Carolina
|
001-35907
|
27-1341991
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
4820 Emperor Blvd.
Durham, North Carolina
|
|
27703
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code:
(919) 998-2000
Not Applicable
(Former
name or former address, if changed since last report)
______________
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⊠
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other Events.
On September 14, 2016, Quintiles Transnational Holdings Inc. (the
“Company”) and IMS Health Holdings, Inc. (“IMS”) issued a joint press
release announcing the pricing of the previously announced senior notes
offering. Under the senior notes offering, IMS’ wholly owned subsidiary,
IMS Health Incorporated, will issue $1,750 million equivalent in gross
proceeds of senior notes consisting of (i) $1,050 million of senior
notes due 2026 bearing interest at a rate of 5.0% and (ii) €625 million
of senior notes due 2024 bearing interest at a rate of 3.5%. The full
text of the joint press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K, was posted on the Company’s internet
website, and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
See the Exhibit Index attached hereto.
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
|
September 14, 2016
|
QUINTILES TRANSNATIONAL HOLDINGS INC.
|
|
|
|
|
|
|
By:
|
/s/ James H. Erlinger III
|
|
|
|
James H. Erlinger III
|
|
|
|
Executive Vice President, General Counsel and Secretary
|
EXHIBIT INDEX
Exhibit
No.
|
|
Description of Document
|
|
|
|
99.1
|
|
Press release dated September 14, 2016
|
IQVIA (NYSE:IQV)
Historical Stock Chart
From Mar 2024 to Apr 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2023 to Apr 2024